Bimatoprost ophthalmic solution in facial vitiligo.
Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes. To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo. Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation. Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response. Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.